June Sherie Almenoff - Jun 30, 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Jennifer Zoltoski, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Jun 30, 2022
Transactions value $
$0
Form type
4
Date filed
7/1/2022, 04:00 PM
Previous filing
Jun 15, 2022
Next filing
Oct 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +4.34K $0.00 4.34K Jun 30, 2022 Common Stock 4.34K $0.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the stock option will immediately vest on the date that it is granted.